Vitro Diagnostic Tests (SAHPRA approved)

Capebio™ SARS-CoV-2 Singleplex RT-qPCR Kit

The Capebio™ SARS-CoV-2 Singleplex RT-qPCR kit is a RT-qPCR ReadyMix™ Kit. It contains the Mutant Reverse Transcriptase, Cod Uracil-DNA Glycosylase and Taq DNA polymerase enzymes that are optimised for convenient generation of complimentary DNA and its subsequent amplification in a single tube. The kit is specific for in vitro detection of SARS-CoV-2 RNA, which is extracted from human clinical samples (i.e., nasopharyngeal, and oropharyngeal swabs) from patients suspected of having COVID-19 by healthcare providers. The kit utilizes the World Health Organization (WHO) recommended primer and probe sets. The kit comes with custom-made Applied Biosystems™ TAQMAN® QSY™ probes. The assay is compatible with Applied Biosystems’s MagMAX™ Viral/Pathogen Nucleic Acid Isolation Kit (cat no. A42352). There are no recorded incompatibilities with existing RNA extraction kits.

Catalogue no COVRT0500 COVRT1000
Number of reactions 500 1000
CapeEnzymes ReadyMix™ (consists of mutant reverse transcriptase, UDG-cod and CapeSprint™ Taq DNA polymerase) 1500 μL 3000 μL
CapeBuffer 10X ReadyMix™ (consists of optimized reaction buffer & dNTPs) 1750 μL 3500 μL
SARS-CoV-2_N-Gene Primers/Probe ReadyMix™ (Reporter: VIC; Quencher: QSY) 1200 μL 2400 μL
SARS-CoV-2_S-Gene Primers/Probe ReadyMix™ (Reporter: ABY; Quencher: QSY) 750 μL 1500 μL
SARS-CoV-2_Human RNaseP_Forward Primers/Probe ReadyMix™ (Reporter: ABY; Quencher: QSY) 1200 μL 3500 μL
SARS-CoV-2 Positive Control (Plasmid DNA) 40 μL 80 μL
Nuclease-Free Water 2000 μL 4000 μL
Capebio™ SARS-CoV-2 Multiplex RT-qPCR Kit

The Capebio™ SARS-CoV-2 Multiplex RT-qPCR kit is a RT-qPCR ReadyMix™ Kit. It contains the Mutant Reverse Transcriptase, Cod Uracil-DNA Glycosylase and Taq DNA polymerase enzymes that are optimised for convenient generation of complimentary DNA and its subsequent amplification in a single tube. The kit is specific for in vitro detection of SARS-CoV-2 RNA, which is extracted from human clinical samples (i.e., nasopharyngeal, and oropharyngeal swabs) from patients suspected of having COVID-19 by healthcare providers. It utilizes the World Health Organization (WHO) recommended primer and probe sets. The kit comes with custom-made Applied Biosystems™ TAQMAN® QSY™ probes. The assay is compatible with Applied Biosystems’s MagMAX™ Viral/Pathogen Nucleic Acid Isolation Kit (cat no. A42352). There are no recorded incompatibilities with existing RNA extraction kits.

Catalogue no COVRT05001 COVRT10001
Number of reactions 500 1000
CapeEnzymes ReadyMix™ (consists of mutant reverse transcriptase, UDG-cod and CapeSprint™ Taq DNA polymerase) 1500 μL 3000 μL
CapeBuffer 10X ReadyMix™ (consists of optimized reaction buffer & dNTPs) 1750 μL 3500 μL
SARS-CoV-2_N-Gene Primers/Probe ReadyMix™ (Reporter: VIC; Quencher: QSY) 1200 μL 2400 μL
SARS-CoV-2_S-Gene Primers/Probe ReadyMix™ (Reporter: ABY; Quencher: QSY) 750 μL 1500 μL
SARS-CoV-2_Human RNaseP_Forward Primers/Probe ReadyMix™ (Reporter: ABY; Quencher: QSY) 1200 μL 2400 μL
SARS-CoV-2_S-Gene Positive Control 40 μL 80 μL
SARS-CoV-2_N-Gene Positive Control 40 μL 80 μL
Nuclease-Free Water 2000 μL 4000 μL